Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC
Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin ...